Isidakamizwa sokuguqula umdlalo we-hepatitis C, iSovaldi (sofosbuvir) , sahlaselwa ekuqaleni kowe-2014 xa kwaziswa ukuba ixabiso elilonke lekhosi leeveki ezili-12 laliyimali engama-84 000, okanye i-$ 1,000 ngepilisi. Nangona iinzame zenziwe ngumenzi, i-Sciences eGiliyadi ukubonelela ukufikelela kumazwe angamahlwempu kunye nabantu ngabanye, indleko ephezulu yeziyobisi ibeka ingcinezelo kwabo banempilo efanelekileyo, kunye neendleko zokuphuma kweefowuni zihlala zikhula kumawaka idola.
Iindaba zibeka kwakhona ukukhanya kwindleko ephezulu yezidakamizwa ezisetyenziselwa ukwelapha i-hepatitis e-US I-3.2 yezigidi zabantu baseMerika abane-Hpatitis C (i-HCV) kunye nabangaphezu kwezigidi ezi-2 abanesifo se-hepatitis B (i-HBV), isidingo sokufikelela kwezidakamizwa ezifikelelekayo ayizange ibe mkhulu.
Ngaphezu koko, kwimbono yomhlaba wonke, phakathi kwabangama-4 ukuya kwezihlanu kwizigidi zabantu abane -HIV kunye neHIV kwilizwe lonke (okanye malunga ne-9% o-HIV).
Inkqubo yokuNxibelelana kunye neNkqubo yokuNcedisa iMonde (PAP) Ukufaneleka
Kwimizamo yokuqinisekisa ukufikeleleka okufikelelekayo, i-Fair Pricing Coalition (FPC) ixoxisane kunye neeprogram zokuncedisa izigulane kunye neenkqubo zokuncedisa isigulane (PAPs) kunye nabaninzi abavelisi beziyobisi be-hepatitis. Zombini iinkqubo zinika uncedo kwizigulane ezihlangabezana neendlela zokufaneleka, ngokusekelwe kwintlawulo yentsapho yasemakhaya okanye kwiNqanaba leNtsholongwane yeNtlupheko (okanye i-FPL) rhoqo ngonyaka. Inkqubo yokufaka ingeniso iyahluka kwiprogram, kunye ne-PAPs, umzekelo, ukubonelela kwabo bafumana imali engaphantsi kwe-500% ye-FPL.
Iimali zeFPL ezisetyenziselwa ukuhlolwa kokufaneleka zifumaneka kwiwebhusayithi ye-Health.gov.
Nangona iiprogram zokuhlawula i-co-aid zincedisa ukuhlawuliswa kwe-inshurensi nganye, i-PAPs isebenza ngokubonelela ngeendleko eziphantsi ukukhupha amayeza okufumana abantu abafanelekileyo. Ukuqinisekiswa kwengeniso kuyimfuneko, ngokuqhelekileyo ngendlela yokubuyisela irhafu yengeniso.
Uphuhliso olutshanje lusekusekwa kweSicelo esiPhakathi sePAP, isicwangciso esilungelelaniswa ngurhulumente wase-US ukuhlaziya inkqubo yofaka isicelo. Ifomu ezalisiweyo iya kufuneka ukuba ifakwe kwinkqubo nganye yonyango yokuncedisa iyeza.
| Iziyobisi | Nkampani | Uqhagamshelwano | Uhlobo lweNkqubo | Iinkcukacha zeProgram |
| Copegus (ribavirin) | Genentech / Roche | 888-941-3331 okanye u tyelele iwebhusayithi ye-Pegasys Access | PAP | Ukhupha abantu abangafanelanga naluphi na olunye uncedo. Ulungelelwaniso luphelelwe ngumvuzo. |
| Daklinza | Bristol-Myers Squibb | 844-442-6663 okanye inkxaso yeBMS yokuxhasana | Co-Pay | Ukufikelela kwi-5,000 kwi-28-day supply. |
| Bristol-Myers Squibb | 800-736-0003 okanye iSiseko soNcediso lwaMonde weBMS | PAP | Ukhupha abantu abangafanelekanga ukuba bafumane olunye uncedo olungena ngaphantsi kwe-250% yeFPL. | |
| Epclusa | KwiSayensi zeGiliyadi | 855-769-7284 okanye iwebsite yeGiliyadi yeNkxaso ye-Path website | Co-Pay | Iyanciphisa iindleko zokuhlawula i-co-coo ukuya kuma-5 ukuya kwizigulane ezifanelekileyo ezifumana imali engaphantsi kwe-$ 100,000 kwintsapho yabantwana abathathu okanye ngaphantsi kwe-500% ye-FPL kwintsapho yabane okanye ngaphezulu. |
| KwiSayensi zeGiliyadi | 855-769-7284 okanye iwebsite yeGiliyadi yeNkxaso ye-Path website | PAP | Inokubonelela ngokubonelela ngokukhululeka kwezigulane ezingenayo imali engama-$ 100,000 kwintsapho yabathathu okanye ngaphantsi kwe-500% ye-FPL kwintsapho yabane okanye ngaphezulu. | |
| Harvoni | KwiSayensi zeGiliyadi | 855-769-7284 okanye iwebsite yeGiliyadi yeNkxaso ye-Path website | Co-Pay | Iyanciphisa iindleko zokuhlawula i-co-coo ukuya kuma-5 ukuya kwizigulane ezifanelekileyo ezifumana imali engaphantsi kwe-$ 100,000 kwintsapho yabantwana abathathu okanye ngaphantsi kwe-500% ye-FPL kwintsapho yabane okanye ngaphezulu. |
| KwiSayensi zeGiliyadi | 855-769-7284 okanye iwebsite yeGiliyadi yeNkxaso ye-Path website | PAP | Unokunika ukubonelela ngehhala kwizigulane ezifumana imali engaphantsi kwama-100,000 kwi-family yabantwana abathathu ingaphantsi kwe-500% ye-FPL kwintsapho yabane okanye ngaphezulu. | |
| Olysio | Janssen Therapeutics | 855-5-OLYSIO okanye iwebhusayithi yezabelo | Co-Pay | Iyancipha ukuhlawula i-co-pay no-5 ngaphezu kwenyanga. Imali yengeniso kufuneka ibe ngaphantsi kwe-500% yeFPL. |
| Janssen Therapeutics | 800-652-6227 okanye iSiseko soNcedo lwabaPhezulu bakaJohn & Johnson | PAP | Inikeza ukunikezelwa kwamahhala ka-Olysio kubantu abafanelekileyo abafumana imali engaphantsi kwe-500% yeFPL. | |
| Genentech / Roche | 888-941-3331 okanye u tyelele iwebhusayithi ye-Pegasys Access | PAP | Ukhupha abantu abangafanelanga naluphi na olunye uncedo. Ulungelelwaniso luphelelwe ngumvuzo. | |
| PegIntron (peginterferon) | Merck | 866-939-4372 okanye iwebhusayithi yomkhiqizo | Co-Pay | Unika izigulane ezifanelekileyo ukuya kwii-200 zeemali zokugcina iimfuno ezifikelela kwi-12. |
| Merck | 866-363-6379 okanye i-Merck isiza iwebhusayithi | PAP | Ukhupha abantu abangafanelanga naluphi na olunye uncedo. Ukulungelelaniswa kuphelelwe ngumvuzo (ngokuqhelekileyo umvuzo wekhaya ongaphantsi kwama-500% we-FPL). | |
| Sovaldi | KwiSayensi zeGiliyadi | 855-769-7284 okanye iwebsite yeGiliyadi yeNkxaso ye-Path website | Co-Pay | Iyanciphisa iindleko zokuhlawula i-co-coo ukuya kuma-5 ukuya kwizigulane ezifanelekileyo ezifumana imali engaphantsi kwe-$ 100,000 kwintsapho yabantwana abathathu okanye ngaphantsi kwe-500% ye-FPL kwintsapho yabane okanye ngaphezulu. |
| KwiSayensi zeGiliyadi | 855-769-7284 okanye iwebsite yeGiliyadi yeNkxaso ye-Path website | PAP | Inokubonelela ngokubonelela ngokukhululeka kwezigulane ezingenayo imali engama-$ 100,000 kwintsapho yabathathu okanye ngaphantsi kwe-500% ye-FPL kwintsapho yabane okanye ngaphezulu. | |
| Viekira Pak | Abbvie | 844-2PROCEED (844-277-6233) okanye iwebhusayithi ye-Abbvie ProCeed | Co-Pay | Izigulane ziyakwazi ukufumana uncedo olufikelela kuma-95% ngoncedo lwentlawulo. |
| Abbvie | 844-2PROCEED (844-277-6233) okanye iwebhusayithi ye-Abbvie ProCeed | PAP | Inokubonelela ngokubonelela ngokukhululeka kwezigulane ezingenayo imali engama-$ 100,000 kwintsapho yabathathu okanye ngaphantsi kwe-500% ye-FPL kwintsapho yabane okanye ngaphezulu. | |
| Zepatier | Merck | 866-251-6013 okanye iwebhusayithi ye-Merck Access | Co-Pay | Iyanciphisa iindleko zokuhlawula i-cookie ukuya ngaphantsi njenge-$ 5 ngenyanga ukwenzela izigulane ezifanelekileyo. |
| Merck | 866-251-6013 okanye iwebhusayithi ye-Merck Access | PAP | Inokubonelela ngeenkonzo ezingabonakaliyo kwizigulane ezingenayo imali engama-59,400 ama-R4,400 okanye abantu abangaphantsi kwama-$ 80,100 okanye ngaphantsi kwiibhangqa, okanye i-$ 121,500 okanye ngaphantsi kwintsapho ye-4 okanye ngaphezulu. |
Imithombo:
Sanger-Katz, M. "I-$ 1,000 I-Hepatitis Pill ibonisa ukuba kutheni ukulungiswa kweendleko zezeMpilo kunzima." ENew York Times; papashwe ngo-Agasti 2, 2014.
Rotman, Y. kunye noLiang, T. "Ukuxhatshazwa nge-Hepatitis C kunye ne-Virus Immunodeficiency Virus: i-Virological, Immunological, kunye neziphumo zeZliniki." Journal of Virology. Agasti 2009; 83 (15): 7366-7374.
Hlela, O .; Locarnini, S .; kunye no-Peters, M. "Virology And Management Clinic ye-Hepatitis B kunye ne-HIV Coinfection." I-PRN Notebook. Epreli 2007; ivolumu 11.